AbCellera Biologics: Pay

AbCellera Biologics paid its 4 named executives $14.3M in total in FY2025 (Dec). CEO Carl L.G. Hansen, Ph.D. was paid $6.3M of that.

Pay$100 in the stock at the end of FY20 → $8
CEO pay is from each proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Pay of each named executive

Carl L.G. Hansen, Ph.D.Chief Executive Officer
FY2025 (Dec)Not disclosed
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)Not disclosed
FY2021 (Dec)Not disclosed
5 years
Andrew BoothChief Financial Officer
FY2025 (Dec)Not disclosed
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)Not disclosed
FY2021 (Dec)Not disclosed
5 years
Tryn StimartChief Legal Officer, Chief Compliance Officer, Corporate Secretary, and Privacy Officer
FY2025 (Dec)Not disclosed
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)Not disclosed
FY2021 (Dec)Not disclosed
5 years
Véronique Lecault, Ph.D.Chief Technology Officer
FY2025 (Dec)Not disclosed
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)Not disclosed
FY2021 (Dec)Not disclosed
5 years

CEO pay against the pay peers

In FY2025 (Dec), the median CEO pay of the 8 peers with pay on file was $7.5M. The CEO of AbCellera Biologics was paid $6.3M, 16% below the median.

  1. 1Xenon Pharmaceuticals
  2. 2Adaptive Biotechnologies
  3. 3Structure Therapeutics
  4. 4Vir Biotechnology
  5. 5Arcutis Biotherapeutics
  6. 6Spyre Therapeutics
  7. 7Nurix Therapeutics
  8. 8AbCellera Biologics
  9. 9Agios Pharmaceuticals
  10. 10AbsciNot disclosed
  11. 11Allogene TherapeuticsNot disclosed
  12. 12Entrada TherapeuticsNot disclosed
  13. 13Ligand PharmaceuticalsNot disclosed
  14. 14Prime MedicineNot disclosed
  15. 15Recursion PharmaceuticalsNot disclosed
  16. 16RegenxbioNot disclosed
  17. 17Relay TherapeuticsNot disclosed
  18. 18Sana BiotechnologyNot disclosed
  19. 19Verve TherapeuticsNot disclosed
  20. 20XencorNot disclosed
  21. 21Y-mAbs TherapeuticsNot disclosed

Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.